20.70

3.01% 0.605

Maplight Therapeutics Inc (MPLT)

Overview News Price History Discussions Forecast

Maplight Therapeutics Inc stock is traded at $20.70, with a volume of 180.68K. It is up +3.01% in the last 24 hours and up +43.15% over the past month. MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Previous Close:

$20.09

Open:

$20.24

24h Volume:

180.68K

Relative Volume:

1.37

Market Cap:

$939.22M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+11.95%

1M Performance:

+43.15%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$20.04

$21.38

1-Week Range:

$18.00

$21.39

52-Week Range:

$12.24

$21.39

Maplight Therapeutics Inc Stock (MPLT) Company Profile

Name

Maplight Therapeutics Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-12-03

Latest SEC Filings

MPLT's Discussions on Twitter

Compare MPLT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MPLT Maplight Therapeutics Inc	20.70	911.77M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Maplight Therapeutics Inc Stock (MPLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-21-25	Initiated	Jefferies	Buy
Nov-21-25	Initiated	Leerink Partners	Outperform
Nov-21-25	Initiated	Morgan Stanley	Overweight
Nov-21-25	Initiated	Stifel	Buy

Maplight Therapeutics Inc Stock (MPLT) Latest News

Dec 08, 2025

Potential Bristol Myers rival MapLight seeks $250M in U.S. IPO - MSN

Dec 08, 2025

Dec 07, 2025

MapLight Therapeutics completes IPO and raises $296.5M - MSN

Dec 07, 2025

Dec 06, 2025

Analysts Offer Insights on Healthcare Companies: MapLight Therapeutics, Inc. (MPLT) and Halozyme (HALO) - The Globe and Mail

Dec 06, 2025

Maplight Therapeutics (MPLT) Stock Trends and Sentiment 2025 - MarketBeat

Dec 06, 2025

Dec 05, 2025

symbol__ Stock Quote Price and Forecast - CNN

Dec 05, 2025

Adversity is less terrifying than hope: MapLight Therapeutics Inc (MPLT) - setenews.com

Dec 05, 2025

Dec 04, 2025

Maplight Therapeutics reports third quarter financial results - marketscreener.com

Dec 04, 2025

MapLight Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com

Dec 04, 2025

MapLight Therapeutics Completes IPO and Raises $296.5M - TipRanks

Dec 04, 2025

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress - The Manila Times

Dec 04, 2025

MapLight Therapeutics, Inc. SEC 10-Q Report - TradingView

Dec 04, 2025

MPLT: Clinical pipeline advances and robust IPO funding position operations through 2027 - TradingView — Track All Markets

Dec 04, 2025

Dec 03, 2025

Positive Outlook on MapLight Therapeutics Amid ADEPT-2 Study Continuation and Upcoming Catalysts - TipRanks

Dec 03, 2025

MapLight stock rises as Jefferies reiterates Buy rating on schizophrenia drug By Investing.com - Investing.com South Africa

Dec 03, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Dec 03, 2025

MapLight stock rises as Jefferies reiterates Buy rating on schizophrenia drug - Investing.com Canada

Dec 03, 2025

Bristol Myers (BMY) Advances in Alzheimer's Study Facing Trial C - GuruFocus

Dec 03, 2025

Dec 02, 2025

SETIA VISHWAS Insider Trades - Nasdaq

Dec 02, 2025

Dec 01, 2025

MapLight Therapeutics (MPLT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 28, 2025

MPLT Interactive Stock Chart | MapLight Therapeutics, Inc. Stock - Yahoo! Finance Canada

Nov 28, 2025

Nov 27, 2025